Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature
Enrica Torretta, Micaela Garziano, Mariacristina Poliseno, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10198-10198
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19
Michele Costanzo, Marianna Caterino, Roberta Fedele, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2414-2414
Open Access | Times Cited: 67
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
Peiran Chen, Mandi Wu, Yaqing He, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 31
Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19
Chiara Bruzzone, Ricardo Conde, Nieves Embade, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 30
Unbiased CSF Proteomics in Patients With Idiopathic Normal Pressure Hydrocephalus to Identify Molecular Signatures and Candidate Biomarkers
Matthijs B. de Geus, Chao‐Yi Wu, Hiroko H. Dodge, et al.
Neurology (2025) Vol. 104, Iss. 5
Closed Access | Times Cited: 1
Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID-19: an observational multicenter study
Nicolas Hoertel, Marina Sánchez‐Rico, Erich Gulbins, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 31
Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis
Hu Meng, Arjun Sengupta, Emanuela Ricciotti, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 11
Open Access | Times Cited: 19
High-throughput analysis of membrane fluidity unveils a hidden dimension in immune cell states
Luca Andronico, Yidan Jiang, Valentina Carannante, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
The effect of antidepressants on the severity of COVID-19 in hospitalized patients: A systematic review and meta-analysis
Hosein Nakhaee, Moein Zangiabadian, R. Bayati, et al.
PLoS ONE (2022) Vol. 17, Iss. 10, pp. e0267423-e0267423
Open Access | Times Cited: 26
Implications of Sphingolipid Metabolites in Kidney Diseases
Shamroop Kumar Mallela, Sandra Merscher, Alessia Fornoni
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4244-4244
Open Access | Times Cited: 25
Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19
Nicolas Hoertel, Marina Sánchez‐Rico, Johannes Kornhuber, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5882-5882
Open Access | Times Cited: 24
Association between antidepressant use and ED or hospital visits in outpatients with SARS-CoV-2
Bradley A. Fritz, Nicolas Hoertel, Eric J. Lenze, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Dynamic modulations of sphingolipids and glycerophospholipids in COVID‐19
Makoto Kurano, Koh Okamoto, Daisuke Jubishi, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 10
Open Access | Times Cited: 23
Development of a targeted hydrophilic interaction liquid chromatography-tandem mass spectrometry based lipidomics platform applied to a coronavirus disease severity study
Zhengzheng Zhang, Madhulika Singh, Alida Kindt, et al.
Journal of Chromatography A (2023) Vol. 1708, pp. 464342-464342
Open Access | Times Cited: 14
COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants—A Scoping Review
Udo Bonnet, Georg Juckel
Journal of Clinical Psychopharmacology (2022) Vol. 42, Iss. 3, pp. 284-292
Open Access | Times Cited: 22
Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model
David Péricat, Stephen Adonai Leon‐Icaza, Marina Sánchez‐Rico, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13623-13623
Open Access | Times Cited: 22
Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination
Shinya Yamada, Hidesaku Asakura
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3338-3338
Open Access | Times Cited: 21
Marked elevations in lung and plasma ceramide in COVID-19 linked to microvascular injury
Irina Petrache, Elisabet Pujadas, Aditya Ganju, et al.
JCI Insight (2023) Vol. 8, Iss. 10
Open Access | Times Cited: 12
SERUM AND PLASMA SPHINGOLIPIDS AS BIOMARKERS OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY
Samia Mohammed, Andreas P. Kalogeropoulos, Victoria Alvarado, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Starve a cold or feed a fever? Identifying cellular metabolic changes following infection and exposure to SARS-CoV-2
Emma K. Loveday, Hope D. Welhaven, Ayten Ebru Erdogan, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0305065-e0305065
Open Access
High density lipoproteins and COVID-19: preparing the next pandemic
Marie Laurine Apalama, Floran Bègue, Sébastien Tanaka, et al.
Journal of Lipid Research (2025), pp. 100779-100779
Open Access
SERUM AND PLASMA SPHINGOLIPIDS AS BIOMARKERS OF CHEMOTHERAPY-INDUCED CARDIOTOXICITY IN FEMALE BREAST CANCER PATIENTS
Samia Mohammed, Andreas P. Kalogeropoulos, Victoria Alvarado, et al.
Journal of Lipid Research (2025), pp. 100798-100798
Open Access
Metatranscriptomic analysis revealed Prevotella as a potential biomarker of oropharyngeal microbiomes in SARS-CoV-2 infection
Sifen Lu, Yongzhao Zhou, Ya Hu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 10
A platelet lipidomics signature in patients with COVID-19
Laura Goracci, Eleonora Petito, Alessandra Di Veroli, et al.
Platelets (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 9
Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study
Nicolas Hoertel, Katayoun Rezaei, Marina Sánchez‐Rico, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1107-1107
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top